Metabolic and Transcriptional Changes in Cultured Muscle Stem Cells from Low Birth Weight Subjects

Ninna S Hansen1, Line Hjort1, Christa Broholm1

  • 1Department of Endocrinology, Diabetes, and Metabolism (N.S.H., L.H., C.B., L.G., M.S., S.W.J., A.V.), Rigshospitalet, 2200 Copenhagen, Denmark; Faculty of Health and Medical Sciences (N.S.H., L.H., A.V.) University of Copenhagen, 1165 Copenhagen, Denmark; The Danish Diabetes Academy (L.H.), 5000 Odense, Denmark; Steno Diabetes Center A/S (B.M., S.W.J.), 2820 Gentofte, Denmark; The August Center (M.F., J.F.P.W.), Department of Nutrition, Exercise, and Sports, University of Copenhagen, 2200 Copenhagen, Denmark; The Centre of Inflammation and Metabolism and the Centre for Physical Activity Research (B.K.P.), Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, 2200 Copenhagen, Denmark; Center for Diabetes Research (B.M.), Gentofte Hospital, University of Copenhagen, 2200 Copenhagen, Denmark; and Novo Nordisk A/S (H.S.S.), 2880 Copenhagen, Denmark.

Insights

Individuals born with low birth weight (LBW) exhibit altered muscle stem cell function, contributing to an increased risk of type 2 diabetes (T2D). These findings highlight intrinsic defects in muscle stem cells from LBW individuals.

Area of Science:

  • Cell Biology
  • Metabolic Diseases
  • Developmental Biology

Background:

  • Low birth weight (LBW) is linked to an increased risk of developing type 2 diabetes (T2D) later in life.
  • Developmental programming of human muscle stem cells may underlie this association.
  • Immature muscle stem cell functions, including abnormal differentiation and metabolic capacity, are hypothesized to connect LBW with T2D risk.

Purpose of the Study:

  • To investigate the functional characteristics of muscle stem cells in individuals born with LBW.
  • To determine if altered muscle stem cell differentiation and metabolic function in LBW individuals contribute to T2D risk.

Main Methods:

  • Recruited 23 young men with LBW and 16 age-matched controls with normal birth weight.
  • Isolated and cultured primary muscle stem cells (satellite cells) into myotubes.
  • Assessed glucose uptake, insulin signaling, myotube maturity markers, DNA methylation, and mitochondrial gene expression.

Main Results:

  • Myotubes from LBW individuals showed reduced glucose uptake and lower levels of glucose transporters (GLUT1, GLUT4).
  • Key myogenic differentiation markers (myogenin, MYH1, MYH2) were decreased in LBW myotubes.
  • Mitochondrial gene expression (PGC-1α, COX7A) was also reduced in LBW myotubes, independent of DNA methylation changes.

Conclusions:

  • Cultured primary satellite cells from LBW individuals exhibit persistent transcriptional and metabolic alterations.
  • These findings suggest an intrinsic defect in muscle stem cells of LBW individuals, potentially contributing to T2D risk.
Abstract